You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINORIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Clinoril patents expire, and when can generic versions of Clinoril launch?

Clinoril is a drug marketed by Merck and is included in one NDA.

The generic ingredient in CLINORIL is sulindac. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulindac profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Clinoril

A generic version of CLINORIL was approved as sulindac by WATSON LABS on April 3rd, 1990.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CLINORIL?
  • What are the global sales for CLINORIL?
  • What is Average Wholesale Price for CLINORIL?
Summary for CLINORIL
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 73
Clinical Trials: 9
DailyMed Link:CLINORIL at DailyMed
Drug patent expirations by year for CLINORIL
Recent Clinical Trials for CLINORIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cancer Prevention Pharmaceuticals, Inc.Phase 3
Stony Brook UniversityPhase 2
Children's Oncology GroupPhase 2

See all CLINORIL clinical trials

US Patents and Regulatory Information for CLINORIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck CLINORIL sulindac TABLET;ORAL 017911-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Merck CLINORIL sulindac TABLET;ORAL 017911-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CLINORIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck CLINORIL sulindac TABLET;ORAL 017911-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Merck CLINORIL sulindac TABLET;ORAL 017911-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Merck CLINORIL sulindac TABLET;ORAL 017911-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.